1. Home
  2. BGLC vs SYNX Comparison

BGLC vs SYNX Comparison

Compare BGLC & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • SYNX
  • Stock Information
  • Founded
  • BGLC 2017
  • SYNX 2005
  • Country
  • BGLC Malaysia
  • SYNX Israel
  • Employees
  • BGLC N/A
  • SYNX N/A
  • Industry
  • BGLC Medical Specialities
  • SYNX
  • Sector
  • BGLC Health Care
  • SYNX
  • Exchange
  • BGLC Nasdaq
  • SYNX Nasdaq
  • Market Cap
  • BGLC 10.4M
  • SYNX 10.2M
  • IPO Year
  • BGLC N/A
  • SYNX 2024
  • Fundamental
  • Price
  • BGLC $5.42
  • SYNX $1.61
  • Analyst Decision
  • BGLC
  • SYNX
  • Analyst Count
  • BGLC 0
  • SYNX 0
  • Target Price
  • BGLC N/A
  • SYNX N/A
  • AVG Volume (30 Days)
  • BGLC 98.4K
  • SYNX 51.7K
  • Earning Date
  • BGLC 11-14-2025
  • SYNX 09-26-2025
  • Dividend Yield
  • BGLC N/A
  • SYNX N/A
  • EPS Growth
  • BGLC N/A
  • SYNX N/A
  • EPS
  • BGLC N/A
  • SYNX N/A
  • Revenue
  • BGLC $9,551,559.00
  • SYNX $6,003,000.00
  • Revenue This Year
  • BGLC N/A
  • SYNX $32.35
  • Revenue Next Year
  • BGLC N/A
  • SYNX N/A
  • P/E Ratio
  • BGLC N/A
  • SYNX N/A
  • Revenue Growth
  • BGLC 4.01
  • SYNX N/A
  • 52 Week Low
  • BGLC $2.01
  • SYNX $1.37
  • 52 Week High
  • BGLC $15.60
  • SYNX $6.49
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 53.36
  • SYNX 50.95
  • Support Level
  • BGLC $5.00
  • SYNX $1.56
  • Resistance Level
  • BGLC $5.37
  • SYNX $1.67
  • Average True Range (ATR)
  • BGLC 0.33
  • SYNX 0.07
  • MACD
  • BGLC 0.01
  • SYNX -0.00
  • Stochastic Oscillator
  • BGLC 62.86
  • SYNX 33.78

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

Share on Social Networks: